Update in Advanced Lung Disease (RP1602E)
Over the past two years, the fields of ILD, PHTN and bronchiectasis have seen medical and technological improvements in the treatment of such diseases. This educational activity will address different pharmacological agents as well as technological advances that have been approved for treatment of these diseases. These new agents and technologies should help improve outcomes and quality of life in patients.
Target Audience
Pulmonologists, Cardiologists, Internists, Residents, Nurse Practitioners, Nurses, and other healthcare workers interested in current options and technologies being utilized in the treatment of advanced lung disease.
Learning Objectives
- Identify patients with PHTN
- Interpret test results and establish disease progression in PHTN
- Identify and distinguish UIP from other forms of ILD illnesses
- Describe the development of bronchiectasis
- Recognize the new technology to assist with airway lesions
Course Director:
Fernando Torres, MD
Medical Director of Lung Transplantation;
Head of the Pulmonary Hypertension Program
Professor
Internal Medicine
UT Southwestern Medical Center
Dallas, Texas
Co- Course Director:
Craig Glazer, MD
Associate Professor
Internal Medicine
UT Southwestern Medical Center
Dallas, Texas
Accreditation and Designation Statements
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Registration
To register:
- Create an account in EthosCE, online learning management system, by selecting the "create an account" link at the bottom of the page or "log-in" to your existing account.
- Return to this course page, select the designated fee and click on "add to cart" at the bottom of the page.
- In the following "checkout" pages you will verify and process your payment.
- After registration is completed, a confirmation will be sent by email.
Available Credit
- 6.00 AMA
- 6.00 Attendance